Select Publications
Journal articles
2014, 'From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases', Journal of Investigative Dermatology, 134, pp. 2298 - 2300, http://dx.doi.org/10.1038/jid.2014.171
,2014, 'Health-related quality of life in epidermolysis bullosa: Validation of the dutch QOLEB questionnaire and assessment in the dutch population', Acta Dermato-Venereologica, 94, pp. 442 - 447, http://dx.doi.org/10.2340/00015555-1758
,2014, 'Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification', Journal of the American Academy of Dermatology, 70, pp. 1103 - 1126, http://dx.doi.org/10.1016/j.jaad.2014.01.903
,2014, 'Report from the inaugural Australian pruritus symposium, Sydney, Australia, August 10, 2013', Acta Dermato-Venereologica, 94, pp. 123, http://dx.doi.org/10.2340/00015555-1732
,2014, 'Scoring systems for blistering diseases in practice: Why bother, and which one should you use?', JAMA Dermatology, 150, pp. 245 - 247, http://dx.doi.org/10.1001/jamadermatol.2013.8179
,2014, 'Efficacité et tolérance à long terme du vismodégib dans le carcinome baso-cellulaire avancé : analyse finale à 30 mois de l’étude pivotale ERIVANCE', Annales de Dermatologie et de Vénéréologie, 141, pp. S288 - S288, http://dx.doi.org/10.1016/j.annder.2014.09.142
,2014, 'Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering', Journal of Pathology, http://dx.doi.org/10.1002/path.4323
,2014, 'Inherited epidermolysis bullosa', Journal of the Egyptian Womenʼs Dermatologic Society, 11, pp. 1 - 13, http://dx.doi.org/10.1097/01.ewx.0000437657.38804.96
,2013, 'Development of an excel® spreadsheet to document disease activity in autoimmune bullous disease', Acta Dermatovenerologica Croatica, 21, pp. 207 - 208
,2013, 'The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease', British Journal of Dermatology, 169, pp. 1000 - 1006, http://dx.doi.org/10.1111/bjd.12623
,2013, 'A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopy', British Journal of Dermatology, 169, pp. 869 - 879, http://dx.doi.org/10.1111/bjd.12430
,2013, 'Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire', JAMA Dermatology, 149, pp. 1186 - 1191, http://dx.doi.org/10.1001/jamadermatol.2013.4972
,2013, 'Daylight PDT: A Convenient, Similarly Effective, and Nearly Painless Alternative to Conventional PDT', JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 11, pp. 87 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323227600269&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Epidermolysis bullosa pruriginosa triggered by scabies infestation', Journal of Dermatology, 40, pp. 562 - 563, http://dx.doi.org/10.1111/1346-8138.12167
,2013, 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 18-month update of the pivotal ERIVANCE BCC study.', Journal of Clinical Oncology, 31, pp. 9037 - 9037, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.9037
,2013, 'Cross cultural adaptation of the 'Quality of Life in Epidermolysis Bullosa' (QOLEB) questionnaire: Validation and results of a Hispanic translation', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 39 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Development, reliability and validity of a novel severity score for epidermolysis bullosa: The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Epidemiology of renal impairment in the Australian epidermolysis bullosa population', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900118&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Prevalence and characterisation of anaemia in patients with epidermolysis bullosa registered in Australia', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Review of cutaneous outcomes of immunomodulatory drugs for multiple sclerosis', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, pp. 49 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine', JAMA Dermatology, 149, pp. 370 - 372, http://dx.doi.org/10.1001/jamadermatol.2013.1463
,2013, 'A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa', Journal of the American Academy of Dermatology, 69, http://dx.doi.org/10.1016/j.jaad.2013.08.014
,2013, 'Bullous pemphigoid: Therapeutic algorithm and practical management', Expert Opinion on Orphan Drugs, 1, pp. 405 - 412, http://dx.doi.org/10.1517/21678707.2013.794693
,2013, 'Management of epidermolysis bullosa', Expert Opinion on Orphan Drugs, 1, pp. 279 - 293, http://dx.doi.org/10.1517/21678707.2013.774274
,2013, 'Measuring quality of life in epidermolysis bullosa in Mexico: Cross-cultural validation of the Hispanic version of the Quality of Life in Epidermolysis Bullosa questionnaire', Journal of the American Academy of Dermatology, 69, pp. 652 - 653, http://dx.doi.org/10.1016/j.jaad.2013.04.053
,2013, 'Successful single-cycle rituximab treatment in a patient with pemphigus vulgaris and squamous cell carcinoma of the tongue and IgG antibodies to desmocollins', Journal of the American Academy of Dermatology, 69, http://dx.doi.org/10.1016/j.jaad.2012.12.967
,2013, 'Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma', British Journal of Dermatology, 169, pp. 208 - 210, http://dx.doi.org/10.1111/bjd.12272
,2013, 'Diffuse melanosis cutis: A systematic review of the literature', Journal of the American Academy of Dermatology, 68, pp. 482 - 488, http://dx.doi.org/10.1016/j.jaad.2012.08.018
,2013, 'Efficacité et tolérance à long terme du vismodegib chez des patients présentant un carcinome basocellulaire avancé (CBCa) : mise à jour à 18 mois de l’étude pivot ERIVANCE CBC', Annales de Dermatologie et de Vénéréologie, 140, pp. S392 - S393, http://dx.doi.org/10.1016/j.annder.2013.09.070
,2013, 'Efficacité et tolérance de la PDT avec Metvix® et lumière du jour dans le traitement des kératoses actiniques : une étude de phase III randomisée, controlée, en simple aveugle', Annales de Dermatologie et de Vénéréologie, 140, pp. S377 - S378, http://dx.doi.org/10.1016/j.annder.2013.09.040
,2013, 'The Pitfalls of Skin Biopsies to Diagnose Epidermolysis Bullosa', Pedatric Dermatology, 30, pp. 273 - 275, http://dx.doi.org/10.1111/pde.120951525-1470
,2013, 'Topically applied flightless i neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita', Journal of Investigative Dermatology, 133, pp. 1008 - 1016, http://dx.doi.org/10.1038/jid.2012.457
,2012, 'Concurrent Management of Toxic Epidermal Necrolysis with Thermal Water Spray and Non-Stick Dressings', Acta Dermatovenerologica Croatica, 20, pp. 210 - 212
,2012, 'APPLICATION OF FLII NEUTRALIZING ANTIBODIES REDUCES THE SEVERITY OF SKIN BLISTERING IN A COLVII MODEL OF EPIDERMOLYSIS BULLOSA ACQUISITA', WOUND REPAIR AND REGENERATION, 20, pp. A60 - A60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'BORON-BASED AN2728 AND AN2898 OINTMENTS DEMONSTRATE SAFETY AND EFFICACY IN A PHASE 2A BILATERAL STUDY OF MILD-TO-MODERATE ATOPIC DERMATITIS', WOUND REPAIR AND REGENERATION, 20, pp. A69 - A69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'INVESTIGATION OF CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB) THROUGH INTRADERMAL INJECTION OF ALLOGENEIC FIBROBLASTS RANDOMIZED AGAINST PLACEBO INJECTIONS OF SUSPENSION SOLUTION', WOUND REPAIR AND REGENERATION, 20, pp. A68 - A68, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'PODIATRY ASSESSMENT FOR EPIDERMOLYSIS BULLOSA', WOUND REPAIR AND REGENERATION, 20, pp. A72 - A72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'REVIEW OF SIDE EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED FOR AUTOIMMUNE BLISTERING DISEASES', WOUND REPAIR AND REGENERATION, 20, pp. A76 - A76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'USE OF CETUXIMAB AS AN ADJUVANT AGENT TO RADIOTHERAPY AND SURGERY IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA WITH SQUAMOUS CELL CARCINOMA', WOUND REPAIR AND REGENERATION, 20, pp. A60 - A60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'VALIDATION OF THE PSYCHOMETRIC PROPERTIES OF A QUALITY-OF-LIFE MEASURE SPECIFIC TO AUTOIMMUNE BULLOUS DISEASE', WOUND REPAIR AND REGENERATION, 20, pp. A65 - A65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Corticosteroid Use in Autoimmune Blistering Diseases', Immunology and Allergy Clinics of North America, 32, pp. 283 - 294, http://dx.doi.org/10.1016/j.iac.2012.04.008
,2012, 'Diagnosis and Clinical Features of Pemphigus Vulgaris', Immunology and Allergy Clinics of North America, 32, pp. 233 - 243, http://dx.doi.org/10.1016/j.iac.2012.04.003
,2012, 'Rituximab and its Use in Autoimmune Bullous Disorders', Immunology and Allergy Clinics of North America, 32, pp. 331 - 337, http://dx.doi.org/10.1016/j.iac.2012.04.013
,2012, 'The Use of Intravenous Immunoglobulin in Autoimmune Bullous Diseases', Immunology and Allergy Clinics of North America, 32, pp. 323 - 330, http://dx.doi.org/10.1016/j.iac.2012.04.012
,2012, 'Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.', Journal of the American Academy of Dermatology, 66, pp. 479 - 485, http://dx.doi.org/10.1016/j.jaad.2011.06.032
,2012, 'Diverse presentations of carcinoma erysipelatoides from a teaching hospital in australia.', Case Rep Dermatol Med, 2012, pp. 134938, http://dx.doi.org/10.1155/2012/134938
,2012, 'Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma complicating patients with recessive dystrophic epidermolysis bullosa.', Cancer Research, 72, pp. 3522 - 3534, http://dx.doi.org/10.1158/0008-5472.CAN-11-2996
,2012, 'Inherited epidermolysis bullosa: New diagnostic criteria and classification', Clinics in Dermatology, 30, pp. 70 - 77, http://dx.doi.org/10.1016/j.clindermatol.2011.03.012
,2012, 'Population-Specific Association between a Polymorphic Variant in ST18, Encoding a Pro-Apoptotic Molecule, and Pemphigus Vulgaris.', Journal of Investigative Dermatology, 132, pp. 1798 - 1805, http://dx.doi.org/10.1038/jid.2012.46
,2012, 'Quality-of-Life Measurement in Blistering Diseases', Dermatologic Clinics, 30, pp. 301 - 307, http://dx.doi.org/10.1016/j.det.2011.11.008
,